Background: Sirt6 plays important roles in metabolism and lifespan, however its role in inflammation is unknown.
INTRODUCTION
Inflammation is a complex biophysical response of the body to pathogen infection and tissue injury. Immune cells are activated during inflammation and are recruited to the site of damage to initiate the healing process by eliminating pathogens and damaged cells (1) (2) (3) (4) . While acute inflammation is considered protective, chronic inflammation is associated with many diseases (5) (6) (7) (8) . Numerous evidence indicates that inflammation is tightly regulated by many factors, including cytokines, signaling molecules and transcription factors, such as transforming growth factor beta (TGF-β), activator protein-1 (AP1), tumor necrosis factor-alpha (TNF-α), nuclear factor kappa B (NF-ҡB), sirtuin-1 (SIRT1), and signal transducer and activator of transcription proteins (STATs); all of which affect or regulate expression of cytokines (1) (2) (3) (4) .
Both SIRT1 and SIRT6 belong to a family consisting of seven sirtuins (SIRT1-7) that share homology with yeast Sir2. These proteins localize to different compartment of the nucleus (SIRT1, 6 and 7), the mitochondrion (SIRT3, 4 and 5), and the cytoplasm/nucleus (SIRT2) (9, 10) . Sirtuins serve as NAD + dependent type III histone deacetylases and also deacetylate many proteins that play important roles in numerous biological processes (11) (12) (13) (14) . Currently, all seven sirtuins (Sirt1-7) have been mutated in mice by gene targeting, and the mutant mice exhibited distinct phenotypes (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) . Sirt1-null mice exhibited the most severe phenotype and died at middle gestation to perinatal stages (23, 24) . Using a tissue specific Sirt1 knockout mouse model to bypass early lethality, it was shown that deletion of Sirt1 in macrophages activates NF-ҡB activity, resulting in increased transcription of several proinflammatory target genes (26) . Sirt1 was also reported to suppress transcriptional activity of AP1 and expression of a pro-inflammatory gene cyclooxygenase-2 (Cox2) in macrophages (27) .
It was previously reported that a strain of Sirt6-deficient mice carrying a targeted disruption of exon 1 died at about 4 weeks of age when they were on a 129 genetic background. These mice displayed profound lymphopenia, loss of subcutaneous fat, lordokyphosis, low insulin and hypoglycemia, and premature aging (17) . Our analysis of Sirt6 -/-mice, generated by a targeted deletion of exons 2 and 3 of the gene that blocks Sirt6 transcription and yields no SIRT6 protein, indicated that about 60% of homozygous mice died before 4 weeks of age when they were in a mixed genetic background of 129/Black Swiss/FVB (28) . Analysis of these mutant mice demonstrated that Sirt6 negatively regulates AKT phosphorylation at Ser-473 and Thr-308 through inhibition of multiple upstream molecules, including insulin receptor, IRS1, and IRS2. The absence of Sirt6, consequently, enhances insulin/Akt/Glut1 mediated glucose uptake, leading to extreme hypoglycemia. Consistent with this hypothesis, when fed with water containing 10% glucose, blood glucose level of the mutant mice was significantly increased and up to 83% of these mice survived beyond the first month after birth. Of note, the majority of these mice, despite their normal levels of blood glucose, still gradually died within one year (28) , suggesting Sirt6 is essential for the adulthood development and survival. Consistent with this data, neural Sirt6 disruption attenuated somatic growth and caused obesity (29) while hepatic specific deletion of Sirt6 resulted in fatty liver formation due to enahnced glycolysis and triglyceride synthesis (30) . Conversely, transgenic mice overexpressing Sirt6 have a significantly longer lifespan than wild-type mice that is accompanied by reduced insulin-like growth factor 1 (IGF1) signaling (31) .
Recent studies have indicated that SIRT6 positively regulates TNF-α (32) and negatively regulates NF-κB signaling (33), although whether or not SIRT6 plays a role in inflammation is unknown. Moreover, as both TNF-α and NF-ҡB are potent pro-inflammatory cytokines, positively regulating one gene while negatively regulating the other generates contradictory information and makes it difficult to predict a role of SIRT6 in inflammation. To decipher the functions of Sirt6 in the inflammatory response, organism survival and lifespan, we analyzed Sirt6 mutant mice that survived post-weaning lethality. Our data indicates that these animals exhibit massive inflammation in several organs, most severely in the liver. We further demonstrate that the absence of Sirt6 results in activation of c-JUN dependent transcription and enhanced expression of proinflammatory genes in immune cells, leading to chronic inflammation and liver fibrosis in the mutant mice. Total RNA from  cells or tissues were extracted with RNA STAT-60  TM following the manufacturer's protocol (TEL-TEST, INC) , and cDNA was generated by Cellsto-cDNA TM II (Ambion, Inc). Quantitative RT-PCR was performed using a SYBR green PCR Master Mix (Applied Biosystems) and the 7500 Real Time PCR system (Applied Biosystems). ChIP assay -ChIP assays were performed as described previously (34) . The antibodies against Ac-H3K9 and Me-H3K4 were purchased from Millipore. Antibody against c-JUN was from Cell Signaling and antibody against SIRT6 was from Sigma.
EXPERIMENTAL PROCEDURES RT-PCR and Real-time PCR -

Western blot analysis and
RNA interference-The sh-c-JUN lentiviral construct was purchased from Sigma (construct TRCN0000360511). The packaging and envelope vectors psPAX2 and VSV-G were obtained from Addgene. 293T cells were transfected with sh-c-JUN or sh-Luci, psPAX2, and VSV-G using Fugene 6 for 24 h. The medium was changed and collected after 24h, respectively. Lentivirus were collected and used to infect the Sirt6 MT and WT macrophages. Twenty-four hours later, cells were harvested for assessing mRNA levels and c-JUN protein level.
In silico analysis-The in silico analysis of promoter was performed by using the software MatInspector from Genomatix Software Gmbh.
Immortalization of macrophages-Immortalized macrophage cell lines were established by infecting primary bone marrow cells from 3 weekold WT and Sirt6 KO mice with the J2 recombinant retrovirus as described (35) . The packaging cell line CREJ2 was adapted from the parental J2 packaging line. CREJ2 contains the murine retroviral ecotropic coat protein, and the virus produced is replication defective. Single cell suspensions from bone marrow were prepared, placed in Dulbecco's modified Eagle's medium and centrifuged through a lymphocyte separation medium cushion (ICN Biochemicals, Aurora, OH). Cells were cocultured with 0.45 micron-filtered CREJ2 supernatants in Dulbecco's modified Eagle's medium supplemented with 10% heatinactivated fetal bovine serum, antibiotics, 2 mM L-glutamine (complete medium) (BioSource International, Camarillo, CA), 5 mg/ml hexadimethrine bromide (Sigma-Aldrich Chemical Co., St. Louis, MO) and 1000 units/ml granulocyte macrophage-colony stimulating factor (PeproTech Inc., Rocky Hill, NJ) for 24 h. Non-adherent cells were removed from cultures and adherent cells were cultured in complete medium with 1000 units/ml granulocyte macrophage-colony stimulating factor and without hexadimethrine bromide. After 5 to 7 days, cells were cultured in complete medium without granulocyte macrophage-colony stimulating factor and monitored for growth. Cells growing in the absence of granulocyte macrophage-colony stimulating factor were considered immortalized.
Kupffer cell isolation from mouse liver and stimulation with LPS-Kupffer cells were isolated as previously described (36) . Isolated Kupffer cells were treated with or without LPS (100ng/ml). Cell supernatant was collected at 4h post-treatment and kept at -80 o C until the levels of the inflammatory cytokines were determined.
Cytokine assays-Inflammatory cytokines were measured using cytometry bead arrays (BD Biosciences, San Jose, CA) according to the manufacturer's protocol.
Mice-Mice carrying a Sirt6
Δ2-3 allele and Sirt6
Co allele were genotyped by PCR using conditions described previously (28, 30) . Mice carrying a Sirt6 neo allele was genotyped using primers F (5'-gggacttgccctgtagatca-3') and R1 (5'-atcgccttctatcgccttcttgacgagttc-3'), WT allele was genotyped using F and R2 (5'-gtccctgcagaagaagatgc-3'); All three lines of cre mice, Alb-Cre (37), Lck-Cre and Lyz-Cre (Provided by Jackson laboratory), were genotyped using primer pair Cre-1(5'-atgcttctgtccgtttgccg-3') and Cre-3 (5'-cctgttttgcacgttcaccg-3'). All experiments were approved by the Animal Care and Use Committee of the National Institute of Diabetes, Digestive and Kidney Diseases (ACUC, NIDDK).
Statistical analyses-Student's t-test was used to compare differences between samples analyzed. Any P-value of <0.05 (P<0.05) was considered as statistically significant difference.
RESULTS
Sirt6
-/-mice exhibited chronic inflammation in the liver-To further study the function of Sirt6, we analyzed Sirt6 -/-mice at varying ages in comparison with wild type control mice. We found that the mutant mice suffered progressively massive inflammation in the liver starting from 2 months of age. Upon dissection, 14 out of 28 Sirt6 mutant mice examined between 2-8 months of age showed white foci on the surface of the liver (Fig.  1A , Table 1 ). As the mutant animals were getting older, the frequency of surface white foci was reduced; however, many animals developed visible nodules and rough surface on the liver (Fig.  1B-D, Table 1 ). H&E analysis on sections cutting through the white foci revealed patches of necrotic cells that were surrounded by leukocytes (Fig. 1F) . Many of these necrotic areas were embedded inside the liver, without displaying white foci on the surface. Leukocytes were found throughout the entire liver of these mice (Fig. 1G) . These abnormalities were not observed in control mice (Fig. 1E,H) Our further analysis indicated that majority of the infiltrated inflammatory cells were CD3 positive (Fig. 1I ). Considerable number of inflammatory cells were also positively stained by markers for macrophage (F4/80) ( Fig. 1J ) and neutrophil markers (MPO) (Fig. 1K) . High levels of interleukin-1 beta (IL-1β), a cytokine that is usually secreted by inflammatory cells, was also detected in the Sirt6 -/-liver ( Fig. 1L) , while the WT controls showed much less staining for these markers ( Fig. 1N-P) . Consistent with these phenotypes, we detected increased transcription of several pro-inflammatory genes in Sirt6 mutant mouse livers, including monocyte chemotactic protein 1 (Mcp-1), Il-6, chemokine C-C motif ligand 5 (Ccl5), Il-1β, cyclin D1, vascular cell adhesion molecule 1 (Vcam), interferon-γ (Ifn-γ), tumor necrotic factor alpha (Tnf-α), and inducible nitric oxide synthase (iNos), as well as C-C chemokine receptor type (Ccr2), marker for monocytes, and F4/80, marker for Kupffer cells/macrophages (Fig. 1Q) . We also detected variable levels of inflammation in several other organs, including kidney, pancreas, and lung, which were much less severe compared to those in the liver (sFig. 1A-F).
We have examined Sirt6 -/-mice (n=6) at age of 9 months and detected elevated serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) compared with wild type mice, however the increase did not reach a statistically significant level (sFig. 2A), suggesting the mutant mice might suffer a slightly or moderately impaired liver function at this age. Sirt6 mutant mice at this age also exhibited moderate, yet non-statistically higher serum levels of IL-6, MCP-1 and TNFα than did the wild type mice (sFig. 2B). Next, we examine liver fibrosis by performing Sirius Red staining on the Sirt6 -/-mouse liver. Our data revealed that significant fibrosis was detected in the Sirt6 -/-livers but not in wild type mouse livers ( Fig. 2A-B) . We also detected some hypercellular areas containing Proliferation Cell Nuclear Antigen positive (PCNA + ) hepatocytes (white arrow, Fig. 2C ),
suggesting increased cellular proliferation. Double staining using antibodies for PCNA and CD3 indicated that some PCNA + cells are CD3 positive (membrane staining, arrowhead), indicating some leukocytes were also proliferative. The staining of these two types of cells only appeared in Sirt6 MT (Fig. 2C ), but not in WT (Fig. 2D) livers. Of note, both antibodies for PCNA and CD3 also stained non-specifically for red blood cells, which have no nucleus (red arrow) in both Sirt6 MT (Fig. 2C) and WT (Fig. 2D) livers. As the liver abnormalities were getting more severe in older animals, we also detected steadily decreased body weight in the older Sirt6 mutant mice (Fig. 2D) . We also detected higher liver weight/body weight (LW/BW) ratio in the Sirt6 mutant mice at 4-6 month of age compared to WT mice (Fig. 2E) , although no significant changes were detected in other age groups. Altogether, these data indicated that Sirt6 mutant mice developed severe liver inflammation, liver fibrosis, and declining health, conditions that might contribute to the lethality that was reported earlier (28) .
Liver inflammation is primarily caused by Sirt6 deficiency in the lymphocytes and myeloidderived cells rather than in the hepatocytes-As the inflammation occurred primarily in the liver, we investigated whether the absence of Sirt6 in hepatocytes is a primary cause for the inflammation. We first examined a mutant strain carrying hepatocytes specific mutation of Sirt6 (Sirt6
Co/Co ;Alb-Cre) (30) , and detected no obvious inflammation in these mice, suggesting Sirt6 deficiency in the hepatocytes alone does not trigger inflammation.
Next we deleted the pLoxPneo gene from the Sirt6 Neo/Neo mice using Alb-Cre to restore Sirt6 expression specifically in hepatocytes (sFig. 3A-B). Our examination of the Sirt6
Neo/Neo ;Alb-Cre mice detected a similar inflammatory phenotype in the liver compared with the Sirt6 -/-liver described earlier (sFig. 3C,D). These data indicate that the inflammation observed in the Sirt6 -/-mice was due to Sirt6 deficiency in the cell types other than hepatocytes.
As T cells and macrophages are predominant immune cells in the inflammatory liver in the absence of Sirt6, we generated two additional mutant strains carrying the T cell specific (Sirt6
Co/Co ;Lck-Cre), and the myeloid-derived cell specific (Sirt6
Co/Co ;Lyz-Cre) knockout of Sirt6, respectively. We revealed that both lines of mice showed liver inflammation, with the latter showing more severe phenotypes than the former, although both of them showed delayed onset of inflammation compared with Sirt6 -/-mice (Supplemental Table 1 ). Both lines of mice also showed some degrees of liver fibrosis (data not shown). These data suggest that the inflammation in Sirt6 -/-mice is caused by Sirt6 deficiency in more than one type of immune cells and the deletion of Sirt6 in myeloid-derived cells correlated with a more severe phenotype than in T cells.
Sirt6 loss activates T cells and myeloid-derived cells leading to liver inflammation-To understand how Sirt6 deficiency in T cells and monocytes
causes liver inflammation, we isolated these cells from the liver, and performed flow cytometry analysis using various antibodies. Our data showed that Sirt6 -/-liver contained a higher frequency of CD4 + T cells compared to those in wild type mice (Fig. 3A) . It has been known that CD4 + T cells can induce contact-independent target cell death through secreting a number of soluble molecules, including IFN-γ (38) . Consistent with this, we observed an increased proportion of IFN-γ secreting CD4 + T cells from Sirt6 -/-liver (Fig. 3A) . It was reported that macrophages and CD4 + T cells often cooperate to trigger a pronounced inflammatory reaction (39, 40) . To investigate this, we isolated Kupffer cells, liver resident macrophages, and found that Sirt6 -/-Kupffer cells had elevated levels of IL-6 and TNFα under LPS stimulation, and elevated basal TNFα level when compared to cells isolated from WT controls (Fig. 3B) . The increased production of IFN-γ, IL-6, and TNFα produced by CD4 + T cells and Kupffer cells in the mutant liver likely serves as a main cause of the liver inflammatory response observed in these mice.
The increase in IFN-γ + CD4 + cells in Sirt6 -/-liver indicated that Sirt6 regulates T cell activation.
To investigate this, we cultured splenocytes with or without anti-CD3 and/or soluble anti-CD28 for 3.5 days, and revealed that Sirt6 -/-T cells showed a significantly higher proliferation rate than did WT splenocytes upon T cell receptor (TCR) stimulation (Fig. 3C ). These data indicate that immune cells in Sirt6 mutant mice are activated even before they migrate to the liver. TGF-β signaling plays an important role in triggering an inflammatory response (4). However, our analysis indicated that both Sirt6 -/-and WT splenocytes exhibited a similar response to TGF-β treatment (data not shown), suggesting Sirt6 loss does not have an obvious effect on the responsiveness of TGF-β signaling. (Fig. 4A,B) , suggesting that Sirt6 -/-cells consistently make more of these cytokines. Upon LPS stimulation, production of these cytokine markedly increased in both type of cells (Fig. 4A,B) , suggesting that Sirt6 is not required for the inducible expression of these cytokines, although our data indicate that Sirt6 -/-cells still produced significantly more MCP-1 than WT cells (Fig. 4B) . Consistent with the changes in IL-6 and MCP-1 production, we also observed a significant increase of the Il-6 and Mcp-1 mRNA levels in the Sirt6 -/-cells (Fig. 4C,D) . The LPS-induced upregulation of Il-6 and Mcp-1 mRNAs requires gene transcription as actinomycin D treatment completely blocked transcription of these genes (Fig. 4E,F) . In addition, we also observed significantly increased mRNA levels of Il-1β, Ccr2, Tnf-α, iNos and F4/80 (Fig. 4G-K) in the Sirt6 -/-macrophage cell line.
Sirt6 deficiency enhances inflammatory cytokine production in macrophages-
Sirt6 deacetylase epigenetically modifies histone in the promoter of pro-inflammatory genes-To investigate the potential mechanims of how Sirt6 deficiency increases expression of proinflammatory genes, we analyzed their promoters. Using an in silico analysis, we detected evolutionarily conserved binding sites for activator protein 1 (AP1) or AP1 related (AP1R) transcription factor in the promoter of both the human and mouse IL-6 and MCP-1 genes (Fig.  5A,B) . Previous studies also indicated that Sirt6 negatively regulates gene expression through deacetylating histone H3 lysine 9 (H3K9) in the promoter of its target genes (30, 33) . To investigate this possibility, we performed ChIP assay of AcH3K9 in the Il-6 and Mcp-1 promoters using the Sirt6 -/-and WT macrophage cell lines. Our data indicated that in the Sirt6 -/-macrophages, AcH3K9 levels on both Il-6 and Mcp-1 promoters dramatically increased in comparison with the WT macrophages (Fig. 5C ). High level of AcH3K9 indicates an open chromatin configuration. Consistently, we detected increased levels of two additional histone markers for open chromatin configuration, Me2H3K4 and Me3H3K4, in the promoter of Il-6 gene (Fig. 5D,E) . However, such an increase was not observed in the Mcp-1 promoter (Fig. 5D,E) ; perhaps, these two modifications do not play an obvious role in the promoter of the Mcp-1 gene, as different promoters may be regulated differently. To investigate this further, we analyzed whether SIRT6 binds to these regions on the promoters of both the Il-6 and Mcp-1 genes. We detected more obvious occupancy of SIRT6 in the promoter of both genes in wild type cells in comparison with Sirt6 -/-cells (Fig. 5F ). These data indicate that SIRT6 binds and deacetylates H3K9 in the by guest on July 16, 2017 http://www.jbc.org/ promoters of these pro-inflammatory genes.
SIRT6 interacts with c-JUN and negatively regulates inflammation signaling-AP-1 is a homodimer or heterodimer protein composed of proteins belonging to the c-FOS, c-JUN, activating transcription factor (ATF) and musculoaponeurotic brosarcoma protein (MBP) families (3, 41) . Activation of c-JUN/AP-1 and increased expression of their downstream proinflammatory genes, including IL-6 and MCP-1, have been found to cause inflammation in several tissues, including skin, lung, and bone (3, 42, 43) . As SIRT6 binds to and deacetylates H3K9 in the promoter of these genes and Sirt6 deficiency results in their upregulation, we hypothesized that SIRT6 and c-JUN might work together to repress the transcription of these genes. To test this hypothesis, we checked their protein interaction, and the data demonstrated that SIRT6 and c-JUN indeed interact with each other (Fig. 5G) . Of note, we also detected remarkably increased levels of c-JUN occupancy in the promoter of these genes in Sirt6 -/-cells (Fig. 5H ). This data suggests that increased expression of these pro-inflammatory genes could be a result of enhanced transcriptional activity of c-JUN upon Sirt6 deficiency. If this is the case, we hypothesized that inhibition of c-JUN should be able to reverse the increased expression of these genes. To test this, we performed c-JUN knockdown in the macrophage cell line and found that Il-6 and Mcp-1 mRNA levels in the Sirt6 deficent cells were brought back to similar levels as observed in the WT cells (Fig. 5I) . This data strongly supports the model that the highly activated inflammatory response in the Sirt6 -/-macrophages was due to activated c-JUN signaling.
DISCUSSION
In this study, we revealed that Sirt6 -/-mice developed invariably chronic liver inflammation starting at about two months of age. Older mutant mice also developed liver fibrosis and some hypercellular areas with increased cellular proliferation. Further analysis indicated that the liver inflammation and fibrosis are mainly caused by the activation of pro-inflammatory signaling in multiple types of immune cells, and we uncovered a novel role for Sirt6 in inhibiting inflammation through repressing c-JUN/AP-1 signaling.
The Sirt6 -/-mice carry a global disruption of Sirt6. Why do they exhibit much more severe inflammation in the liver than other tissues? The liver is an organ that plays an essential role in removing pathogens, antigens, and viruses entering from the circulation. Upon infection or injury, leukocytes are recruited to the liver through hepatic sinusoids, which are low-flow vascular channels (1, 44) . The accumulation of leukocytes and their slow clearance, in addition to the large quantity of Kupffer cells may serve as a source for initiation of inflammation and fibrosis. In this study, we found that Sirt6 deficiency activates multiple types of leukocytes, including T cells, Kupffer cells, and monocytes in other organs leading to wide spread inflammation. However the inflammation is most pronounced in the liver. To reinforce this model, we have performed the following three experiments: 1) specific disruption of Sirt6 in hepatocytes, 2) restoration of Sirt6 transcription in the hepatocytes specifically in Sirt6 -/-mice, and 3) deletion of Sirt6 in T cells or myeloid-derived cells. All these experiments came up with the same conclusion that Sirt6 deficiency in the immune system causes liver inflammation and fibrosis, while loss of Sirt6 in the hepatocytes alone does not result in inflammation.
In theory, liver inflammation can be initiated by abnormalities in hepatocytes, leukocytes, or the combination of both (45) . For example, targeted disruption of the tumor suppressor gene, cylindromatosis (CYLD), specifically in hepatocytes resulted in liver inflammation, fibrosis, and cancer (46) . In this case CYLD deficiency triggers hepatocyte death via spontaneous and chronic activation of TGF-β activated kinase 1 (TAK1) and c-JUN N-terminal kinase (JNK). There is subsequent compensatory proliferation leading to tumorigenesis when the animals reached 1 year of age. In contrast, Sirt6 -/-mutant liver does not exhibit obvious apoptosis revealed by Tunel assay (data not shown), and does not have statistically significant elevation of serum ALT and AST. This suggests that Sirt6 deficiency in hepatocytes does not cause strong liver injury. These observations may explain why loss of Sirt6 in hepatocytes alone does not cause inflammation. We have also examined 12 Sirt6 -/-mice between 11 to 17 months of age and did not detect cancer formation in the liver and other organs. Thus, it is unlikely that Sirt6 has a tumor suppressor function in mice. While recent studies have indicated that Sirt1 (24, 47) , Sirt2 (48) , and Sirt3 (49,50) may suppress tumorigenesis in mice and Sirt7 may promote it (51), it is conceivable that Sirt6 plays a distinct role in this process.
The most notable finding in this study is that Sirt6 deacetylase plays an essential role in mediating the inflammatory response through inhibiting c-JUN signaling. Both c-JUN and its activator, c-JUN-N-terminal kinase (JNK), play an important role in many biological processes, including apoptosis, cell differentiation and proliferation, metabolism, and tumorigenesis in the liver (52) . We showed here that SIRT6 binds to the promoters of both IL-6 and MCP-1 and deacetylates H3K9. Loss of Sirt6 results in enhanced expression of these genes, suggesting that Sirt6 negatively regulates their expression. Our data clearly demonstrates that loss of Sirt6 enhanced c-JUN occupancy in the promoters of these genes, and more importantly, shRNA mediated acute knockdown of c-JUN reversed activated transcription of these genes in Sirt6 mutant cells. These observations provide strong evidence that Sirt6 deficiency enhances Il-6 and Mcp1 gene expression through activation of c-JUN transcriptional activity.
A previous study indicated that SIRT6 interacts with the NF-ҡB RelA subunit and deacetylates H3K9 at NF-ҡB target gene promoters, loss of Sirt6 caused activation of NF-ҡB dependent gene expression, and haploinsufficiency of RelA rescues the early lethality and degenerative syndrome of Sirt6 deficient mice (33) . However, it was also reported that over-expression of wild type or a catalytically dead mutant of SIRT6 do not influence NF-ҡB responses (53 In summary, previous studies have revealed that Sirt6 is involved in many important biological processes, including glucose metabolism, lipid metabolism, triglyceride synthesis, DNA damage repair, telomere maintenance, and lifespan regulation (17, 28, 30, 31, 55, 56) . Our study uncovers a novel anti-inflammatory role of Sirt6 through inhibiting c-JUN signaling. This finding may have a significant clinic application in the future as chronic inflammation causes many dieseases including fatty liver diseases, cirrhosis and hepatocarcinoma (5) (6) (7) (8) . In this case, small chemical compounds that activate Sirt6 deacetylase should be useful in therapeutic treatment to decrease inflammation and improve patient symptoms.
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